2.130
−1,39%
2026-10-19
Fundamental Analysis
26 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -101.9% | -62.2% | 1 / 3 | +25.6% | -0.80 pp | -0.10 pp | +1.7% | 2.01 | 11.90 | 408 | +25,6% | −0,0 | −101,9% | 11.90 | 10.37 | +14,8% |
| Pts | 0 | 0 | 4 | 12 | 4 | 4 | 0 | -4 | 8 | |||||||
Valuation annotation:Price: 2.130 (close price on 2026-10-19)EPS (TTM): 179,0
Financial charts
1.Revenue & growth
VND bn408Q2/26
1.Revenue & growth
VND bn408Q2/26
2.Profit & growth
VND bn-0,07Q2/26
3.Profit mix (Penman)
VND bn5,79Q2/26
4.Margins & cost structure
%5.0%Q2/26
5.Returns & cash cycle
% · days2.0%Q2/26
6.Earnings quality & cash
VND bn
7.Asset structure
VND bn837Q2/26
8.Funding & debt health
VND bn · times837Q2/26
9.Revenue backlog
VND bn1,48Q2/26
10.Valuation
times · %12,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-3Q2/26
Adjusted EPS growth, latest quarter
-124%
Average adjusted EPS growth, 3 quarters
-69.5%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26